1-215786825-T-G

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_206933.4(USH2A):ā€‹c.10232A>Cā€‹(p.Glu3411Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.538 in 1,613,422 control chromosomes in the GnomAD database, including 235,006 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E3411D) has been classified as Benign.

Frequency

Genomes: š‘“ 0.58 ( 25969 hom., cov: 31)
Exomes š‘“: 0.53 ( 209037 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 2.96
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Fibronectin type-III 19 (size 94) in uniprot entity USH2A_HUMAN there are 15 pathogenic changes around while only 5 benign (75%) in NM_206933.4
BP4
Computational evidence support a benign effect (MetaRNN=3.6495892E-6).
BP6
Variant 1-215786825-T-G is Benign according to our data. Variant chr1-215786825-T-G is described in ClinVar as [Benign]. Clinvar id is 48344.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-215786825-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.677 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
USH2ANM_206933.4 linkuse as main transcriptc.10232A>C p.Glu3411Ala missense_variant 52/72 ENST00000307340.8 NP_996816.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkuse as main transcriptc.10232A>C p.Glu3411Ala missense_variant 52/721 NM_206933.4 ENSP00000305941 P1O75445-1
USH2AENST00000674083.1 linkuse as main transcriptc.10232A>C p.Glu3411Ala missense_variant 52/73 ENSP00000501296 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.580
AC:
88021
AN:
151814
Hom.:
25934
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.683
Gnomad AMI
AF:
0.591
Gnomad AMR
AF:
0.579
Gnomad ASJ
AF:
0.527
Gnomad EAS
AF:
0.633
Gnomad SAS
AF:
0.493
Gnomad FIN
AF:
0.559
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.525
Gnomad OTH
AF:
0.586
GnomAD3 exomes
AF:
0.548
AC:
137379
AN:
250598
Hom.:
38053
AF XY:
0.543
AC XY:
73614
AN XY:
135468
show subpopulations
Gnomad AFR exome
AF:
0.687
Gnomad AMR exome
AF:
0.575
Gnomad ASJ exome
AF:
0.534
Gnomad EAS exome
AF:
0.634
Gnomad SAS exome
AF:
0.495
Gnomad FIN exome
AF:
0.552
Gnomad NFE exome
AF:
0.521
Gnomad OTH exome
AF:
0.547
GnomAD4 exome
AF:
0.533
AC:
779652
AN:
1461490
Hom.:
209037
Cov.:
69
AF XY:
0.532
AC XY:
387031
AN XY:
727052
show subpopulations
Gnomad4 AFR exome
AF:
0.694
Gnomad4 AMR exome
AF:
0.568
Gnomad4 ASJ exome
AF:
0.533
Gnomad4 EAS exome
AF:
0.632
Gnomad4 SAS exome
AF:
0.496
Gnomad4 FIN exome
AF:
0.552
Gnomad4 NFE exome
AF:
0.525
Gnomad4 OTH exome
AF:
0.543
GnomAD4 genome
AF:
0.580
AC:
88111
AN:
151932
Hom.:
25969
Cov.:
31
AF XY:
0.581
AC XY:
43104
AN XY:
74250
show subpopulations
Gnomad4 AFR
AF:
0.684
Gnomad4 AMR
AF:
0.579
Gnomad4 ASJ
AF:
0.527
Gnomad4 EAS
AF:
0.633
Gnomad4 SAS
AF:
0.493
Gnomad4 FIN
AF:
0.559
Gnomad4 NFE
AF:
0.525
Gnomad4 OTH
AF:
0.585
Alfa
AF:
0.539
Hom.:
44504
Bravo
AF:
0.586
TwinsUK
AF:
0.533
AC:
1977
ALSPAC
AF:
0.526
AC:
2029
ESP6500AA
AF:
0.672
AC:
2959
ESP6500EA
AF:
0.519
AC:
4462
ExAC
AF:
0.547
AC:
66335
Asia WGS
AF:
0.558
AC:
1939
AN:
3476
EpiCase
AF:
0.526
EpiControl
AF:
0.534

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 16, 2023- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 02, 2012Caucasian data = 3655/7020 (ESP data) -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 06, 2013- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 05, 2011This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Usher syndrome type 2A Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Retinal dystrophy Benign:1
Benign, criteria provided, single submitterresearchDept Of Ophthalmology, Nagoya UniversityOct 01, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.036
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
13
DANN
Benign
0.14
DEOGEN2
Benign
0.020
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.38
T
MetaRNN
Benign
0.0000036
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-2.0
N
MutationTaster
Benign
1.0
P;P
PrimateAI
Benign
0.35
T
PROVEAN
Benign
2.3
N
REVEL
Benign
0.086
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.076
MPC
0.031
ClinPred
0.0064
T
GERP RS
4.9
Varity_R
0.033
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10864198; hg19: chr1-215960167; COSMIC: COSV56336661; API